Fidelity Investments
GYRE icon

Fidelity Investments’s Gyre Therapeutics GYRE Stock Holding History

Fidelity Investments’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.7K Sell
14,974
-3,743
-20% -$25.5K ﹤0.01% 3980
2026
Q1 		$130K Buy
18,717
+8,413
+82% +$65.3K ﹤0.01% 3692
2025
Q4 		$72.7K Buy
10,304
+100
+1% +$772 ﹤0.01% 3916
2025
Q3 		$76.1K Sell
10,204
-688
-6% -$5.22K ﹤0.01% 3779
2025
Q2 		$80.1K Buy
10,892
+10,516
+2,797% +$91.7K ﹤0.01% 3698
2025
Q1 		$2.9K Sell
376
-880
-70% -$9.65K ﹤0.01% 4825
2024
Q4 		$15.2K Sell
1,256
-2,486
-66% -$31.8K ﹤0.01% 4299
2024
Q3 		$46.9K Buy
+3,742
New +$48.2K ﹤0.01% 3805
2023
Q2 		– Hold
0
– – – 5475
2023
Q1 		– Hold
0
– – – 5394
2021
Q4 		– Hold
0
– – – 4601
2021
Q3 		– Hold
0
– – – 4631
2021
Q2 		– Sell
-11
Closed – – 4511
2021
Q1 		$0 Hold
11
– – ﹤0.01% 4213
2020
Q4 		$1K Buy
+11
New +$476 ﹤0.01% 3692
2015
Q4 		– Sell
-350
Closed -$184K – 2745
2015
Q3 		$184K Sell
350
-372
-52% -$567K ﹤0.01% 2687
2015
Q2 		$1.59M Buy
722
+63
+10% +$126K ﹤0.01% 2481
2015
Q1 		$1.54M Sell
659
-16
-2% -$33K ﹤0.01% 2454
2014
Q4 		$1.4M Buy
675
+15
+2% +$28.9K ﹤0.01% 2489
2014
Q3 		$1.31M Buy
660
+164
+33% +$405K ﹤0.01% 2496
2014
Q2 		$1.76M Sell
496
-31
-6% -$101K ﹤0.01% 2423
2014
Q1 		$1.97M Sell
527
-19
-3% -$70.3K ﹤0.01% 2386
2013
Q4 		$1.78M Buy
546
+16
+3% +$63.1K ﹤0.01% 2372
2013
Q3 		$2.22M Sell
530
-5,384
-91% -$21.7M ﹤0.01% 2325
2013
Q2 		$19.9M Buy
+5,914
New +$22.5M ﹤0.01% 1666

Other funds holding GYRE

HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Fidelity Investments's GYRE Position: Q2 2026 in Review

Fidelity Investments reduced its Gyre Therapeutics (GYRE) stake by 20% in Q2 2026, selling an estimated $25.5K and leaving 14,974 shares worth $98.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3980.

Fidelity Investments first reported a position in GYRE in Q2 2013 and has held it in 20 quarters since. The position peaked at $19.9M in Q2 2013. 60 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • Fidelity Investments held 14,974 shares of Gyre Therapeutics worth $98.7K as of Q2 2026.
  • Fidelity Investments sold 3,743 Gyre Therapeutics shares in Q2 2026, an estimated $25.5K.
  • Gyre Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3980 holding.
  • Fidelity Investments first reported a position in Gyre Therapeutics in Q2 2013 and has held it in 20 quarters since.
  • Fidelity Investments's Gyre Therapeutics position peaked at $19.9M in Q2 2013.
  • 60 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.